Evoke Pharma (EVOK) Institutional Ownership $2.66 +0.06 (+2.12%) Closing price 07/1/2025 03:50 PM EasternExtended Trading$2.64 -0.02 (-0.75%) As of 04:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Evoke Pharma (NASDAQ:EVOK)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$461.93KNumber ofInstitutional Sellers(last 12 months)0 Get EVOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Evoke Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVOK Institutional Buying and Selling by Quarter Evoke Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Nantahala Capital Management LLC148,194$655K0.0%+163.5%9.946% 11/14/2024Corsair Capital Management L.P.11,667$56K0.0%N/A1.425% 11/9/2021BlackRock Inc.175,559$228K0.0%+9.2%0.541% 11/2/2021Raymond James Financial Services Advisors Inc.108,545$141K0.0%-8.9%0.335% 8/17/2021Worth Venture Partners LLC397,742$545K0.2%+18.2%1.229% 8/16/2021Sabby Management LLC47,431$65K0.0%N/A0.147% 8/13/2021Geode Capital Management LLC195,760$268K0.0%+22.4%0.605% 8/13/2021Vanguard Group Inc.1,120,178$1.53M0.0%-1.5%3.460% 8/12/2021AIGH Capital Management LLC1,701,185$2.33M0.4%+18.7%5.255% 5/20/2021Axiom Investment Management LLC17,500$32K0.0%N/A0.054% 5/19/2021Worth Venture Partners LLC336,516$616K0.3%N/A1.040% 5/18/2021Morgan Stanley723,897$1.33M0.0%+43.6%2.236% 5/18/2021Jane Street Group LLC18,044$33K0.0%N/A0.056% 5/12/2021UBS Group AG31,757$58K0.0%+1,709.5%0.098% 5/7/2021BlackRock Inc.150,891$276K0.0%+8.2%0.466% (Data available from 1/1/2016 forward) EVOK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVOK shares? During the previous two years, the following institutional investors and hedge funds held shares of Evoke Pharma shares: Nantahala Capital Management LLC ($655K), Corsair Capital Management L.P. ($56K).Learn more on Evoke Pharma's institutional investors. Which institutional investors have been buying Evoke Pharma's stock? The following institutional investors have purchased Evoke Pharma's stock in the last 24 months: Nantahala Capital Management LLC ($91.95K), and Corsair Capital Management L.P. ($11.67K). How much institutional buying is happening at Evoke Pharma? Institutional investors have bought a total of 103,612 shares in the last 24 months. This purchase volume represents approximately $461.93K in transactions. Related Companies MRKR Major Shareholders PMN Major Shareholders CASI Major Shareholders HOTH Major Shareholders CLRB Major Shareholders CGTX Major Shareholders LPTX Major Shareholders BFRG Major Shareholders XFOR Major Shareholders GELS Major Shareholders This page (NASDAQ:EVOK) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evoke Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evoke Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
